What's Happening?
Dr. Emmanuella Amoako, a pediatric oncologist, has been awarded the 2026 Roux Prize by the Institute for Health Metrics and Evaluation (IHME) for her significant contributions to childhood cancer care in Ghana. As the Lead Pediatric Oncologist at Cape
Coast Teaching Hospital, Dr. Amoako has developed evidence-driven services that enhance early diagnosis and expand access to treatment. Her work focuses on overcoming access barriers in Ghana, where specialist services are limited to urban centers, requiring families to travel long distances for care. Dr. Amoako's initiatives include establishing a shared-care pediatric oncology service, which allows children to receive part of their treatment locally while maintaining connections to comprehensive cancer centers. This service has benefited over 150 children, improving treatment adherence and coordination across facilities.
Why It's Important?
Dr. Amoako's work is crucial in addressing the disparity in childhood cancer survival rates between high-income countries and African settings. In many high-income countries, survival rates exceed 80%, while in Africa, they are often below 30%. By improving early detection and expanding access to care, Dr. Amoako is helping to close this gap. Her efforts also highlight the importance of locally led research and evidence-based practices in enhancing healthcare outcomes. The recognition by IHME underscores the global significance of her work and the potential for similar models to be implemented in other regions facing similar challenges.
What's Next?
Dr. Amoako plans to continue her work in Ghana, focusing on strengthening childhood cancer diagnosis, cancer genetics, and precision oncology. Her ongoing efforts aim to further expand pediatric oncology services and improve early detection rates. Additionally, her role as Director of Clinical Affairs at Yemaachi Biotech and her involvement with The African Cancer Atlas initiative will contribute to building a comprehensive genomic and clinical resource for African populations. These initiatives are expected to generate evidence that better represents African populations and improve patient care across the continent.
